HilliardFSeiglerMD
General Surgery • Durham, NCSurgical Oncology (Other than Breast)
Professor, Surgery, Duke University School of Medicine
Are you Dr. Seigler?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 32 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
508 Fulton St
Durham, NC 27705Phone+1 919-286-6939
Summary
- Dr. Hilliard Seigler, MD is a general surgeon in Durham, North Carolina. He is currently licensed to practice medicine in North Carolina. He is affiliated with Durham Veterans Affairs Medical Center and is a Professor at Duke University School of Medicine.
Education & Training
University of North Carolina HospitalsResidency, Plastic Surgery - Integrated, 1963 - 1965- University of North Carolina HospitalsResidency, Surgery, 1960 - 1963
University of North Carolina at Chapel Hill School of MedicineClass of 1960
Certifications & Licensure
NC State Medical License 1960 - 2023- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal Start of enrollment: 1997 Jul 01
Publications & Presentations
PubMed
- 80 citationsImpact of core-needle breast biopsy on the surgical management of mammographic abnormalitiesRebekah R. White, Terri J. Halperin, John A. Olson, Mary Scott Soo, Rex C. Bentley
Annals of Surgery. 2001-06-01 - 143 citationsANALYSIS OF 945 CASES OF PULMONARY METASTATIC MELANOMADavid H. Harpole, Cheryl M. Johnson, Walter G. Wolfe, Stephen L. George, Hilliard F. Seigler
The Journal of Thoracic and Cardiovascular Surgery. 1992-04-01 - 7844 citationsMutations of the BRAF gene in human cancerHelen Davies, Graham R. Bignell, Charles Cox, Philip J. Stephens, Sarah Edkins
Nature. 2002-06-27
Press Mentions
- Preclinical Evaluation of Cancer Immune Therapy Using Patient‐Derived Tumor Antigen‐Specific T Cells in a Novel Xenograft PlatformFebruary 2nd, 2021
Professional Memberships
- Member
